/

Ricerca sul cancro

/

Generasjon av prostata kreft cellen modeller av motstand mot anti-mitotisk Agent Docetaxel

JoVE Journal
Ricerca sul cancro

This content is Free Access.

JoVE Journal Ricerca sul cancro

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Generasjon av prostata kreft cellen modeller av motstand mot anti-mitotisk Agent Docetaxel

12,685 Views

•

06:44 min

•

September 08, 2017

DOI:

10.3791/56327-v

DOI:

10.3791/56327-v

•

06:44 min

September 08, 2017

•

4 Views

Lisa Mohr, Marc Carceles-Cordon, Jungreem Woo, Carlos Cordon-Cardo, Josep Domingo-Domenech, Veronica Rodriguez-Bravo²

¹Department of Pathology, Tisch Cancer Institute,Icahn School of Medicine at Mount Sinai, ²Department of Oncological Sciences, Tisch Cancer Institute,Icahn School of Medicine at Mount Sinai

Tags

Docetaxel-resistant Prostate Cancer Cell Models Cancer Cell Resistance Anti-mitotic Therapy Resistance Drug Response Models Cell Line Development DU145 Cells 22Rv1 Cells Dose Escalation Cell Culture Trypsinization Cell Passaging Pooled Resistant Cells

Read Article